TT‑1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl‑2 and Bax

  • Authors:
    • Lanlan Wan
    • Daqi Zhang
    • Jinnan Zhang
    • Liqun Ren
  • View Affiliations

  • Published online on: November 8, 2017     https://doi.org/10.3892/ol.2017.7366
  • Pages: 1271-1278
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Melittin is a 26 amino acid residue antimicrobial peptide with known antitumor activity. In the present study, a novel peptide TT‑1, derived from melittin and contained only 11 amino acids, was designed, and its antitumor effect was investigated. The present study is aimed to elucidate the effects and relative mechanisms of TT‑1 on a human thyroid cancer cell line (TT) in vitro and in vivo. Cell viability assays, Annexin V/propidium iodide assays, western blotting and quantitative reverse transcription polymerase chain reaction were performed. Furthermore, a tumor‑xenograft model was established to investigate the apoptotic mechanisms of TT‑1 on TT cells. The results obtained indicated that TT‑1 was able to suppress the proliferation of TT cells and exhibited low cytotoxicity to normal thyroid cells in vitro. The apoptotic rates of TT cells were also increased following TT‑1 treatment. Additionally, TT‑1 stimulated caspase‑3, caspase‑9 and Bax, and inhibited B‑cell lymphoma 2 mRNA and protein expression. Finally, it was also demonstrated that TT‑1 is able to markedly suppress tumor growth in a TT‑bearing nude mouse model. In summary, TT‑1 may inhibit the proliferation of TT cells by inducing apoptosis in vitro and in vivo, indicating that TT‑1 may be a potential candidate for the treatment of thyroid cancer.
View Figures
View References

Related Articles

Journal Cover

January-2018
Volume 15 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wan L, Zhang D, Zhang J and Ren L: TT‑1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl‑2 and Bax. Oncol Lett 15: 1271-1278, 2018
APA
Wan, L., Zhang, D., Zhang, J., & Ren, L. (2018). TT‑1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl‑2 and Bax. Oncology Letters, 15, 1271-1278. https://doi.org/10.3892/ol.2017.7366
MLA
Wan, L., Zhang, D., Zhang, J., Ren, L."TT‑1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl‑2 and Bax". Oncology Letters 15.1 (2018): 1271-1278.
Chicago
Wan, L., Zhang, D., Zhang, J., Ren, L."TT‑1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl‑2 and Bax". Oncology Letters 15, no. 1 (2018): 1271-1278. https://doi.org/10.3892/ol.2017.7366